Search results for: Pricing and Reimbursement
Filter search results
Around the World in HTAs: Spain – Closer than ever, but not quite yet
8 July 2026
…reforms – a draft Royal Decree on medicines pricing and reimbursement and a new Medicines and Medical Devices Bill – are still moving through the policy pipeline. Together, these texts…
Beyond opportunity cost: what are health systems for? The UK–US pharmaceutical agreement and the limits of QALY maximisation
23 October 2026
…thousands of additional deaths a year and as many as 330,000 over the decade to 2036. Professor Andrew Briggs and Dr Francis Ruiz warnthat an unfunded increase in the drugs bill…
The Importance of Diversity of Supply in Rare Diseases Markets
23 January 2025
…to expand RD policies to prioritise medicine shortage mitigation, supplier diversity, and supply resilience. HTA, pricing and reimbursement, and procurement policies can help reduce barriers to the availability of medicines…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…introducing effective HTA and related priority setting mechanisms in order to support both the introduction of universal health care and more efficient pricing and reimbursement mechanisms based on value-based pricing….
Reflections from Adrian Towse on decades of HEOR research and impact
11 November 2025
…Pay for something else and you will get something else. Hence my motivation in writing and arguing for value-based pricing as a means of putting the static and dynamic pieces…
Would Waiving COVID-19 Vaccines Patents Save Lives?
18 May 2021
…of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic. Available at: https://www.ohe.org/news/key-learnings-covid-19-importance-portfolio-management-and-how-procure-pay-distribute-and-use [Accessed 17 May 2021]. Steuten, L., Bell, E. and Neri, M.,…
How long are patients WAITing for new treatments?
2 July 2026
…(JCA) report under the new EU HTA Regulation was published in June 2026. The JCA introduces a centralised clinical assessment that will inform national pricing and reimbursement decisions, and is…
Around The World in HTAs: Greece – Late but with an Optimistic Future
18 October 2023
…The regulatory framework for the authorisation, pricing, and reimbursement of pharmaceutical products falls within the scope of Ministerial and Interministerial decisions on pharmaceutical products. It should be noted that the…
Around The World in HTAs: The Netherlands – 5 Routes for New Tech
24 May 2023
…Netherlands, Luxembourg, Austria and Ireland is the BeNeLuxA initiative, which aims to improve collaboration on pharmaceutical policy and procurement by means of horizon scanning, HTA, information sharing and policy exchange,…